Prostaglandin d synthase is a potential novel therapeutic agent for the treatment of gastric carcinomas expressing PPARγ

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0215|137|5|1235-1244

ISSN： 0020-7136

Source： INTERNATIONAL JOURNAL OF CANCER, Vol.137, Iss.5, 2015-09, pp. : 1235-1244

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lipocalin-type prostaglandin D synthase is not a biomarker of atherosclerotic manifestations

By Hosbond Susanne E.   Diederichsen Axel C. P.   Pedersen Lise   Rasmussen Lars M.   Munkholm Henrik   Gerke Oke   Poulsen Tina S.   Mickley Hans  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 74, Iss. 3, 2014-04 ,pp. : 219-227

Informa Healthcare

Access to resources Recommend Favorite

Donepezil, a potential therapeutic agent for heart failure

By  

EUROPEAN JOURNAL OF HEART FAILURE, Vol. 17, Iss. 2, 2015-02 ,pp. : 233-233

John Wiley & Sons Inc

Access to resources Recommend Favorite

Relaxin: A Novel Agent for the Treatment of Acute Heart Failure

By  

PHARMACOTHERAPY: THE JOURNAL OF HUMAN PHARMACOLOGY AND DRUG THERAPY, Vol. 35, Iss. 3, 2015-03 ,pp. : 315-327

John Wiley & Sons Inc

Access to resources Recommend Favorite

Indirubin: a novel topical agent in the treatment of psoriasis

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 178, Iss. 1, 2018-01 ,pp. : 21-21

John Wiley & Sons Inc

Access to resources Recommend Favorite

Therapeutic potential of antiangiogenic agents for prevention and treatment of obesity

By Cao Yihai   Cao Renhai   Xue Yuan  

Future Lipidology, Vol. 3, Iss. 2, 2008-04 ,pp. : 153-162

Future Medicine

Access to resources Recommend Favorite